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c Cochlear Limited e Asia Pacific, 1 University Avenue, Macquarie University, NSW 2109, AustraliaAbstractBackground: Currently, there is a significant lack of data concerning long-term outcomes following paediatric cochlear implantation in terms of
quality of life. There is a need for a long-term, prospective study in this regard. This study aims at highlighting the preliminary results, one year
post surgery of a five year prospective study.
Methods: The Cochlear™ Paediatric Implanted Recipient Observational Study (P-IROS) is a prospective, patient outcomes registry for routinely
implanted children. The study collects data using questionnaires post-surgery and at regular intervals up to five years.
Results: At our Centre, 159 cochlear implant surgery procedures were carried out between January 2014 and December 2014. Category of
Auditory Performance II score increased from ‘0’ to ‘3’ at six months and to ‘5’ at 12 months for children aged 0e3 years, although this was not
statistically significant. However, the same trend was statistically significant for the age 3e6 year and age 6e10 year brackets. The quality of life
of the child improved significantly. Analysis of communication mode revealed a statistically significant overall shift to the auditory-oral mode
from total communication.
Conclusion: Cochlear implantation is a life-changing intervention. The evidence in support of what it can achieve safely is clear. However, the
costs associated with it raise the question if it will remain an effective option for life in all children. The Cochlear P-IROS is an attempt to answer
the same over a five year period. Our study in New Delhi, so far concludes that cochlear implantation in a population with limited access to funds
is very effective, one year after surgery.
Copyright © 2015, PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Cochlear implant surgery; Hearing loss; Cochlear implant outcome; Category of Auditory Performance; Quality of life1. Introduction
Hearing loss affects about 5.3% (approximately 360
million) of the world's population (World Health
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1672-2930/Copyright © 2015, PLA General Hospital Department of Otolaryngolo
Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://crto profound hearing loss is defined as hearing loss of
61 dBHL or more in the better ear (Mathers et al., 2000). Its
incidence is estimated to be 4.8% in children aged 0e1 years
and 6.4% in children aged 1e4 years (Sanderson et al., 2014).
Prevalence and severity of hearing loss vary with some fac-
tors including socioeconomic status, exposure to infections,
and consanguinity (Stevens et al., 2013). Lower income and
increasing age lead to increased incidence of hearing loss
(Stevens et al., 2013).gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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profound hearing loss is cochlear implantation. Candidates
include children born with the permanent bilateral sensori-
neural hearing loss (Balkany et al., 2001, 2002). The
impairment may range from moderate in the low frequencies
sloping towards severe to profound in the higher frequencies.
Apart from cochlear implantation, in the mild to moderate
category of deafness, other options are also very effective,
such as air conduction hearing aids, bone conduction hearing
aids and middle ear implants. Children with absent cochlea
and cochlear nerve can be candidates for brain stem implant.
Research over the last few decades has revealed cochlear
implant surgery to be a safe option for children and adults,
with a major complication rate of 1.6% for children
implanted bilaterally under the age of 18 years (Broomfield
et al., 2013).
Despite advances in medical technology, clinics around the
world have individualized clinical practices based on clinician
training and expertise, published literature, and practices
unique to that area. The available data to support uniform
evidence-based practice is still very low. The National Institute
for Health and Care Excellence (NICE) in the UK reviewed
the body of evidence of cochlear implants and although rec-
ommended provision of bilateral simultaneous cochlear
implant surgery for children born deaf, acknowledged lack of
evidence in the field (Bond et al., 2009). Similarly, the Na-
tional UK Audit of Paediatric cochlear implantation between
2010 and 2012 revealed strongly positive evidence in favor of
the same (Cullington et al., 2013). However, the study did not
measure the quality of life or other humanistic measures
including education placement and literacy.
There seemed the need for a standardized electronic patient
registry for the collection of data of cochlear implant re-
cipients (Raz, 2005; Berrettini et al., 2011a) even though it
was proposed that the same may be very costly (Berrettini
et al., 2011b).
In an attempt to generate consistent collated and reported
data set for cochlear implant recipients, the Cochlear™ Paedi-
atric Implanted Recipient Observational study (Cochlear™ P-
IROS) was developed by Cochlear™. This global, prospective,
observational study, facilitates a unified approach for the
assessment of patients worldwide in a structured format. The
Cochlear P-IROS study design is based on the primary hy-
pothesis of intra-subject improvement in auditory performance
of children using implantable hearing devices across the world.
The objectives of the Cochlear P-IROS study are:
1. To evaluate the longitudinal improvements in auditory
performance with implantable hearing aid devices in
children using standardized questionnaires.
2. To provide statistically significant data to support patient
management decisions at the clinical, regulatory, payer
and policy level.
3. To compare the patient related or humanistic benefits such
as educational placement, quality of life and patient
satisfaction resulting from use of hearing implants in
unilateral, bilateral and bimodal configurations.This study has been conducted in an Indian private hospital
setting, where funding for children from a lower socioeco-
nomic demographic group was provided by a philanthropic
foundation.
2. Material and methods
This study is part of the Cochlear P-IROS (Cochlear™
Paediatric Implanted Recipient Observational Study), a pro-
spective, longitudinal, observational, international, multi cen-
ter, patient outcomes registry for routinely implanted children.
The study collects data using standardized and generic ques-
tionnaires at regular intervals up to five years through a secure
web interface. The Cochlear P-IROS protocol and evaluation
forms used have been described in detail previously
(Sanderson et al., 2014). To date, clinics from Belarus, China,
Cuba, India, Indonesia, Taiwan and Turkey have joined this
study apart from our clinic.
Data were collected on patient comorbidities, device use,
auditory performance, and quality of life, across different
types of implantable hearing devices from a range of manu-
facturers. Patients were evaluated with a set of questionnaires
prior to initial device activation (baseline) and at six monthly
follow-up intervals up to 24 months and then annually
thereafter.
The specific inclusion and exclusion criteria of the study
are as follows:
Inclusion criteria:
1. Newly implanted prelingual and perilingual patients less
than age 10 years, prior to the first time the hearing
implant system is activated by the fitting of the sound
processor.
2. Unilateral, bilateral or bimodal users of cochlear implants,
electroacoustic devices, bone conduction implants, or
other implantable hearing systems.
3. Parent/caregiver and/or patient are cognitively able to
respond to self-administered/proxy assessment scales and
willing to participate and sign the Patient Consent Form.
Exclusion criteria:
1. Patients with previous implant experience. This includes
all brands and types of cochlear, bone conduction, elec-
troacoustic and auditory brain stem implant systems.2.1. Study periodThe current study describes the outcomes six months and
12 months after surgery. It is planned that these patients will
be followed up until five years from surgery.2.2. Ethical and consent considerationsThis study was evaluated and received ethical approval by
the Columbia Asia Hospitals (Palamvihar, Gurgaon, and
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parents signed a written consent form after the patient was
implanted to ensure the decision to participate in the registry
remains independent of the type and brand of the device
implanted.2.3. Questionnaires used for evaluation includedEvaluation forms for the clinician:
Clinician baseline form
Clinician follow-up form
The Categories of Auditory Performance e II (CAP-II)
Unaided hearing threshold form
Aided hearing threshold form
End of study form
Evaluation forms for the parent/caregiver:
Implant recipient baseline/follow-up forms
Children using hearing implants Quality of Life
(CuHIeQoL)
The primary outcome measure was the CAP-II, a stan-
dardized measure of the perceived functional hearing of the
child, from the clinician's perspective (Gilmour, 2010). The
CuHIeQoL was used as the secondary outcomes measure, to
evaluate the perceived quality of life of the child, expecta-
tions for the child, and the impact/burden on the family, from
the parent-proxy perspective (Sanderson et al., 2014). This
evaluation form was developed in collaboration with aca-
demics and clinical experts in the hearing implant industry
(Sanderson et al., 2014). Validation of the CuHIeQoL is
underway in Australia (Sanderson et al., 2014).
Following forms were recommended as optional by
Cochlear P-IROS protocol (Sanderson et al., 2014) and not
used in this study:
Health Utilities Index e Mark III (HUI 3)
Speech spatial and qualities of hearing scale (SSQ)
SSQ e Parents version2.4. Study hypothesisa. Post Implant performance for all patients on the Cate-
gories of Auditory PerformanceeII (CAPeII) are superior
to pre-implant performance (baseline) and show incre-
mental improvement at each subsequent post-implant
assessment points (6, 12, 18, 24 months and annually up
to 5 years) during the study.
b. Post implant assessment of quality of life for the patient
and family via the CUHIeQoL questionnaire as assessed
by the parent or caregiver are superior to quality of lifeassessed at baseline (pre-implant) and show incremental
improvement at each subsequent post-implant evaluation
time point (6, 12, 18, 24 months and annually thereafter
for up to 5 years) during the study.
c. Patients who enter mainstream school during the study
enter at an age-appropriate time.
d. The proportion of patients who are participating in
mainstream school with no additional support is higher
than the proportion of patients in other categories of
school placement.2.5. Study implementationThe baseline forms were completed after surgery, before
discharge from hospital or prior to first switch-on of the
sound processor. The follow-up questionnaires were
completed in the clinic at the time of follow-up visits, coor-
dinated by a patient coordinator who is well versed in the
study. A clinician and other approved clinic staff entered the
data into the Cochlear P-IROS web-based platform online
after the patient/caregiver had completed the questionnaires
given to them in their local language in print. No identifiable
personal data were collected in any of the forms or preserved
in the database. An automated query system built into the
Cochlear P-IROS web platform ensured high data quality and
integrity.2.6. Statistical analysisCategorical variables were summarized using percentages
while continuous data were summarized using means and
standard deviations (SDs). Significance at the 0.05 level was
examined using Pearson's chi-square for education placement
and Spearman rho, for parent/clinician satisfaction. The pri-
mary endpoint (CAP-II over time) was analyzed using an
ordinal mixed-effects model including time, and age at im-
plantation as fixed effects, and the participant as a random
effect. The results of this model showed the odds of being in
a higher category compared with the current category over
time, at any given timepoint. Age at implantation was
adjusted for, since it has been shown to be significantly
associated with outcome (Bond et al., 2009). Summary sub-
scales of the CuHIeQoL (Child's QoL, Impact on Family,
and Parent Expectations) were analyzed using linear mixed-
effects models also adjusting for age at implantation. Given
the percentage of missing data was small (<10%) for the
majority of variables, missing data were not imputed. Sta-
tistical analyses were performed using the RStudio Version
0.98.1074 (Windows).
3. Results
At our Centre, 159 cochlear implant surgery procedures
were carried out by the first author between January 2014 and
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Fig. 2. Etiology of deafness for paediatric and non-paediatric patients.
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Cochlear CI24RE (ST) with CP802 sound processor; 42 re-
cipients of the Advanced Bionics 1J with Harmony sound
processor; and five recipients of the Digisonic SP cochlear
implant and sound processor. Of 159 patients, 150 were
implanted at less than age 120 months and constituted the
paediatric population. These patients were enrolled and
analyzed in the PeIROS platform.
A rate of follow-up at 90% was achieved at six months. At
the time of analysis, the primary measure, the CAP-II was
completed for 146 children at baseline, 135 children at six
months, and 48 children at 12 months. The latter figure was
low due to staggered nature of patient recruitment, i.e., at time
of analysis, 12-month follow-up was not due for majority of
the patients.
The main source of referral to this practice were Audiolo-
gists (73%) and parents of other children (12%) who had been
operated in our centre (Fig. 1). Other sources of referral for
paediatric patients included ENT surgeons (9%), General
Practitioners (GP's) (3%), Speech Therapists (1%), and others
(1%).
The mean age at implantation was 4.95 years (54.9 months)
with a standard deviation of 1.89 years (22.7 months). The
minimum age of implantation was 15 months. 25 children
were operated at ages 0e3 years, 81 children at 3e6 years and
44 children at 6e10 years. The etiology of deafness was un-
known in the majority of patients (Fig. 2).
Analysis of the socioeeconomic profile of these pa-
tients revealed both fathers and mothers to be largely
educated up to secondary school (48% and 49%, respec-
tively). Most of the fathers were employed in mid-level
non-professional jobs (85%), and almost all mothers
were housewives (92%). Around 45% and 46% of the
patients belonged to the ‘middle-income’ (<8000 USD per
annum) and ‘low-income’ (<5000 USD per annum)
brackets, respectively.Audiologist
Ear Nose and Throat (ENT) surgeon
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Infant hearing screening
Other
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Fig. 1. Sources of referral for paediatric and non-paediatric patients.For recipients' aged 0e3 years, the CAP-II score increased
from ‘0’ to ‘3’ at six months and ‘5’ at 12-month follow-up,
although this was not statistically significant (Fig. 3). How-
ever, the same trend was statistically significant (p < 0.05) for
the age 3e6 year and age 6e10 year groups (Fig. 3). These
CAP-II scores are defined as;
 ‘0’, No awareness of environmental sound or voice.
 ‘3’, Identification of environmental sounds.
 ‘5’, Understanding of common phrases without lip reading
Quality of life of the child, measured by the CuHIeQoL
scale improved significantly (p < 0.05) for the cohort as a
whole. So did the impact on family (p < 0.05). Parent ex-
pectations realistically dropped after the first three months
(Fig. 4).
Analysis of communication mode changes revealed a statis-
tically significant (p< 0.001) overall shift to auditory-oral mode
from total communication, defined as ‘a combination of visual
cues, audition, and cued speech’ in all age groups (Fig. A1).
For children who had not yet entered school in the age 3e6
year group, one can see the shift from staying at home to a
preschool intervention where possible, at baseline (Fig. A2).
Also evident was the greater frequency towards mainstream
integration in the age 6e10 year group (Fig. A2).
For the paediatric cohort, parent versus clinician satisfac-
tion at six month follow-up were largely aligned on most
fronts, including hearing, listening, language development,
and overall progress (Rho: 0.62, 0.63, 0.55, and 0.21,
respectively; p < 0.001). A similar trend was also observed at
12-month follow-up (Spearman's Rho: 0.55, 0.39, 0.55, and
0.36, respectively; p < 0.001).
No patients have dropped out of the study yet. Overall the
primary hypothesis predicting a significant improvement in
CAP-II score stands proven from this study. However, long
term 2e5 year outcome using the same platform will bring out
the final fate of children operated at this centre.
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Fig. 3. The performance in the CAP-II for all paediatric CI recipients, and by age at implantation. Abbreviations: CAP, categories of performance; CI, cochlear
implant. Notes: The figure highlights the mean and median (shown in numbers) CAP-II performance of CI recipients, from baseline to six and 12-month follow-up.
In Panel A, the performance of all children who received a CI at age <10 years is shown; whereas in Panels BeD, the performance of different age sub-groups are
illustrated. These CAP-II scores are defined as;  ‘0’, No awareness of environmental sound or voice.  ‘3’, Identification of environmental sounds.  ‘4’,
Discrimination of speech sounds without lip reading.  ‘5’, Understanding of common phrases without lip reading.
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The Cochlear P-IROS has supported a unique collection of
outcomes data from a large cohort of children using cochlear
implants. At the six month and 12 month follow-up intervals,
children have made significant progress in their auditory per-
formance. Our current results are a snapshot of the outcomes
noted at one year from the start of the study in an Indian
private hospital setting.
Analysis of the source of referral of these patients
revealed a unique referral pattern probably typical of a
developing country in the Indian subcontinent. A huge ma-
jority of these children were referred by Audiologists. The
next largest category were parents of other patients. ENT
surgeons and GPs referred the least number of patients and
Paediatricians seemed to not refer at all. Most of these pa-
tients have access primarily to private care with philanthropic
funding support. State screening for hearing loss is patchy
and not effective. When parents note that their child is
typically not speaking any words around the age of two, they
take him or her to the local audiologist who then refers to aCochlear Implant Program. Paediatricians do not refer
directly to a Cochlear Implant Program. It is possible that
they refer these children to the local audiologists who then
take the lead in these childrens' treatment. It is also possible
that the Paediatricians and most GPs are not looking out for
hearing loss. Another reason may be that they are not very
well networked to ENT surgeons and fulfill their re-
sponsibility by handing the case to an Audiologist. Contrary
to previous anecdotal information, this fact is a stark new
one. It is probably more important to direct activities related
to increasing awareness and creating interest about Cochlear
Implants through Audiologists than Paediatricians or GPs as
is the case currently in India.
The maximum number of children, who were implanted in
this program were in the age range of 3e6 years. The next
highest frequency was in the age 6e8 year range, and least of
all were in the ideal age of implantation of less than age 3
years. This could be because of delay in diagnosis, but it
could also be due to nonavailability of funding options.
Universal Neonatal screening for hearing loss is adopted by
most new hospitals in India, however in the vast majority of
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Fig. 4. The performance in the CuHIeQoL scale for all paediatric CI re-
cipients. Abbreviations: CuHIeQoL, Children using Hearing Implants Quality
of Life; CI, cochlear implant; QoL, quality of life. Notes: The figure shows the
mean performance in the CuHIeQoL for all paediatric CI recipients, across
time. Significant differences (p < 0.05) were observed in ‘Parent expectations’,
‘Impact/burden on family’, and ‘Child's QoL’ sub-scales, when compared with
baseline, at six month and 12-month follow-up intervals.
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figure as standard practice. As such parents suspect hearing
loss only when the child is expected to speak and does not,
such as at age two years. It is difficult for the parent to make
the decision in favor of Cochlear Implant surgery in good
time. They take time to decide and arrange for funds since the
same is not provided by state (other than few exceptional
ones) or covered by insurance and the price of treatment even
with a low-cost device is well beyond what they can afford.
Non-involvement of Paediatricians and GPs in the referral
process further adds to the delay.
The etiology of hearing loss could not be established in
most cases. Within our study setup, the investigation of eti-
ology of disease did not compulsorily include Genetic testing
due to extra costs involved there. Viral infections, prematurity
and history revealing an inherited pattern were the most
common etiologies observed in this cohort (Fig. 2).
Education of fathers and mothers was mostly at second-
ary school level. While most mothers were housewives only,
fathers were in all kinds of low to medium level skilled jobs
with almost none in high paying professional roles like
Lawyers and Doctors. This was the case since almost all
patients enrolled in this program were funded by an external
philanthropist and, therefore, the program sub-selected those
patients who needed financial support. The annual income
of the vast majority of these patients was less than 8000
USD.4.1. Category of Auditory Performance-II (CAP-II) scoreThe CAP-II score increased from ‘0’ at baseline to ‘3’ at six
months, and ‘5’ at 12 months, in the age 0e3 years group
(Fig. 3). However, these trends were not statistically signifi-
cant in this group. The reason for this most likely is not in the
poor performance of this group but instead in the small
numbers of children in this age group. We say this because of
the trends noted in the other age groups as described next. In
the age 3e6 years and age 6e10 years groups, the score
improved from ‘0’ at baseline to ‘4’ at six months and ‘5’ at
one year. These trends were strongly statistically significant
(p < 0.001). As expected, with uncomplicated surgery and
good early rehabilitation, these patients are performing at
levels expected of them. Surprisingly this trend is also seen in
those implanted after the age of six. It may be that this group
will plateau off in their performance earlier than the younger
groups in future assessments.4.2. Quality of lifeThe CuHIeQoL questionnaire evaluating parent expecta-
tions revealed a statistically significant shift to reduced ex-
pectations after six and 12 months (Fig. 4). This was expected
as initial expectations at the time of surgery are replaced by
more realistic ones as the parents gather more information
about how the device works and the importance of rehabili-
tation in due course. The impact on family increased from
baseline to six months as the need to maintain and manage the
cochlear implant speech processor was added to their re-
sponsibilities as well as the time and resources that now
needed to be spent on taking the child for mapping and
rehabilitation regularly. This change was statistically signifi-
cant for the group (Fig. 4).
The child's quality of life improved significantly from
baseline to six months and 12 months as captured by the
questionnaire (Fig. 4). Access to even environmental sounds
adds significantly to the child's happiness. Receptive language
development to even CAP score of ‘4’ to ‘5’ added hugely to
the child's ability to bond with the immediate family. This
resulted in a sea-change in behavior and confidence of the
child. The same child who was frustrated and screaming all the
time was now much more calm and collected and interested in
all our review meetings. This was so even if his receptive and
expressive language skills were still far from reaching their
optimum levels. The questionnaire captured this aspect of the
child's development very well.
There were large variations in the CuHI- QOL scores that
indicated variability in parent/caregiver perceptions of the
family's expectations for the child, the potential impact/
burden, and child's quality of life, especially at baseline
(Fig. 4). These variations in the scores tended to drop by the
12-month follow up, once outcomes were more measureable
for these families.
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12-month intervals revealed a statistically significant shift
from total communication to auditory-oral mode for all age-
at- implantaton groups (Fig. A1). The change to auditor-
yeoral mode was more marked in the age <3 years group.
One could not compare the relative difference with the 12-
month timepoint since the overall number of children who
reached 12 months after surgery was small at this point in
time. The overall statistically significant move in the right
direction indicates that cochlear implantation is a very
successful intervention for children age from one to eight
years. At 12-month follow-up, they are still improving in
their learning of receptive and expressive hearing, speech
and language.4.4. Mainstream schoolingIn the age <3 years age group, there was no statistically
significant move to education outside home although there was
a visible trend (Fig. A2). This is understandable given the
young age of the children and also the relatively small number
of children in this group. In the age 3e6 years group, a sta-
tistically significant number of children not yet in school,
moved from home to schooling options such as preschool,
nursery and child care (Fig. A2). Cochlear implantation
clearly empowered them and their families with the confi-
dence that they will be functional and safe outside of home. In
the age 6e10 years age group, the trend towards shifting to
mainstream schooling and other outside home options is
visible but the same was not statistically significant (Fig. A2).
This may be owing to some limitation in this age group to
adapt to the outside home environment. Whether they can
overcome this in due course of time with rehabilitation and
training would be interesting to note in further follow-up of
this study. Whether time and training can make up for the loss
of neural plasticity in this age group will get answered in
1.5e3 years follow-up.4.5. Parent vs clinician satisfactionThe study investigated if parent and clinicians satisfaction
with recipient's progress were aligned at six months and 12
months after surgery. At six months, there was a moderate but
statistically significant correlation between parent and clini-
cian satisfaction in hearing progress, listening progress and
language development and limited but significant correlation
in overall progress. In the age 0e3 years group, there was a
significant alignment in hearing progress only. In the age 3e6years group, there was a significant alignment in all domains.
In the age 6e10 years group, there was significant alignment
in hearing, listening, and language only but not in overall
progress.
At 12-month follow-up there was a significant alignment
of parent and clinician satisfaction in hearing progress,
listening progress, language development but not in overall
progress. For age 0e3 years group there was no significant
alignment in parent and clinicians satisfaction at 12-month
follow-up. In the age 3e6 years group, there was signifi-
cant alignment in listening progress only. In the age 6e10
years group, parent and clinician satisfaction was well
aligned and statistically significant in hearing, language and
overall progress. At younger ages, parents' expectations did
not match with that of the clinicians satisfaction. However the
same was better aligned in the older age groups. The rela-
tively smaller number of children that were followed-up to 12
months may also be affecting the trends reflected in this study
at current stage.5. Conclusion
Cochlear implantation is a life-changing intervention. This
has been established beyond doubt. The evidence in support of
what it can achieve safely in terms of developing receptive and
expressive speech and language is clear. However, the crucial
need for auditory verbal training and mapping, the need to
maintain an external and internal bionic device, the costs
associated with paying for initial treatment and later main-
taining it for life, raise the question if it will remain an
effective option for life, for all who receive it. The P-IROS is
an attempt to answer the same over a five year period in
various populations, worldwide.
Our study in New Delhi, India, so far concludes that
cochlear implantation in a population with limited access to
funds is very effective, one year after surgery. It will be very
interesting to see the performance of this cohort of patients
five years later.Acknowledgement
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of communication of children from baseline to six months and 12 months, across all age groups examined (p < 0.001). At baseline, the majority of children had
‘Total Communication’, defined as a combination of visual cues, audition, and cued speech.
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Fig. A2. Education placement of paediatric CI recipients at baseline, by age at
implantation. Abbreviations: CI, cochlear implant; FTMS, full-time main-
stream, HI, hearing impaired. Notes: The figure shows the educational status
of paediatric CI recipients at baseline, by age at implantation. The analysis of
educational placement at six and 12-month follow-up was limited by the
incompleteness of the data. However, it is rare to observe a dramatic change in
the education status over a period of 12 months.
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